Masataka Sata
Department of Cardiovascular Medicine
University of Tokyo Graduate School of Medicine
Tokyo and PRESTO
Japan Science and Technology Agency
Kawaguchi
Name/email consistency: medium
- Molecular strategies to treat vascular diseases: circulating vascular progenitor cell as a potential target for prophylactic treatment of atherosclerosis. Sata, M. Circ. J. (2003)
- Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Sata, M., Saiura, A., Kunisato, A., Tojo, A., Okada, S., Tokuhisa, T., Hirai, H., Makuuchi, M., Hirata, Y., Nagai, R. Nat. Med. (2002)
- Role of Fas/Fas ligand interaction in ischemia-induced collateral vessel growth. Sata, M., Hirata, Y., Nagai, R. Hypertens. Res. (2002)
- Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia. Sata, M., Nishimatsu, H., Suzuki, E., Sugiura, S., Yoshizumi, M., Ouchi, Y., Hirata, Y., Nagai, R. FASEB J. (2001)
- Acute and chronic smooth muscle cell apoptosis after mechanical vascular injury can occur independently of the Fas-death pathway. Sata, M., Sugiura, S., Yoshizumi, M., Ouchi, Y., Hirata, Y., Nagai, R. Arterioscler. Thromb. Vasc. Biol. (2001)
- A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. Sata, M., Maejima, Y., Adachi, F., Fukino, K., Saiura, A., Sugiura, S., Aoyagi, T., Imai, Y., Kurihara, H., Kimura, K., Omata, M., Makuuchi, M., Hirata, Y., Nagai, R. J. Mol. Cell. Cardiol. (2000)
- Cyclosporine downregulates Fas ligand expression on vascular endothelial cells: implication for accelerated vasculopathy by immunosuppressive therapy. Sata, M., Walsh, K. Biochem. Biophys. Res. Commun. (1999)